While it has been in research for over 20 years, it has recently gained a second life thanks to the massive public interest in peptide therapy and the rise of GLP-1 medications.
Curr Med Chem 21(32):36623672 Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID (2006) Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption
Eccentric strengthening, hip stabilization, and core work complement the peptides tissue repair effects
Unlike many peptides with low oral bioavailability, BPC-157 stands out due to its gastric origin and high oral bioavailability
E.JeongG